YearPaper
2010 Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vre E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med. 2010 Aug 2;207(8):1579-87. Epub 2010 Jul 5.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20603314
2010 Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Bluml S, Grebien F, Bruckner M, Pasierbek P, Aumayr K, Planyavsky M, Bennett KL, Colinge J, Knapp S, Superti-Furga G. CD14 is a co-receptor of Toll-like receptors 7 and 9. J Exp Med. 2010 Nov 22;207(12):2689-701. Epub 2010 Nov 15.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21078886
2010 Bieghs V, Wouters K, Van Gorp PJ, Gijbels MJ, De Winther MP, Binder CJ, Lutjohann D, Febbraio M, Moore KJ, Van Bilsen M, Hofker MH, Shiri-Sverdlov R. Role of Scavenger Receptor A and CD36 in Diet-induced Non-alcoholic Steatohepatitis in Hyperlipidemic Mice. Gastroenterology. 2010 Jun;138(7):2477-86, 2486.e1-3. Epub 2010 Mar 2.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20206177
2010 Binder CJ. Natural IgM Antibodies Against Oxidation-Specific Epitopes. J Clin Immunol. 2010 May;30 Suppl 1:S56-60.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20387104
2010 Bluml S, Binder NB, Niederreiter B, Polzer K, Hayer S, Tauber S, Schett G, Scheinecker C, Kollias G, Selzer E, Bilban M, Smolen JS, Superti-Furga G, Redlich K. Anti-inflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis. Arthritis Rheum. 2010 Jun;62(6):1608-19.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20155834
2010 Boucheron N, Sharif O, Schebesta A, Croxford A, Raberger J, Schmidt U, Vigl B, Bauer J, Bankoti R, Lassmann H, Epstein MM, Knapp S, Waisman A, Ellmeier W. The protein tyrosine kinase Tec regulates a CD44hiCD62L-Th17 subset. J Immunol. 2010 Nov 1;185(9):5111-9. Epub 2010 Sep 24.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20870948
2010 Bunk S, Sigel S, Metzdorf D, Sharif O, Triantafilou K, Triantafilou M, Hartung T, Knapp S, von Aulock S. Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood. J Immunol. 2010 Sep 15;185(6):3708-17. Epub 2010 Aug 16.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20713893
2010 Burkard TR, Rix U, Breitwieser FP, Superti-Furga G, Colinge J. A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib. PLoS Comput Biol. 2010 Nov 18;6(11):e1001001.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21124949
2010 Cardilo-Reis L, Witztum JL, Binder CJ. When monocytes come (too) close to our hearts. J Am Coll Cardiol. 2010 Apr 13;55(15):1639-41.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20378084
2010 Colinge J, Rix U, Superti-Furga G. Novel global network scores to analyze kinase inhibitor profiles. 2010 Sep 9, ORSC & APORC, 305-313. Lecture Notes;
Abstract:
2010 Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. Peroxisomes are signaling platforms for antiviral innate immunity. Cell. 2010 May 14;141(4): 668-81. Epub 2010 May 6.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20451243
2010 Guenzl P, Hainzl E, Matt U, Dillinger B, Mahr B, Knapp S, Binder BR, Schabbauer G. Anti-inflammatory properties of the phosphoinositide- 3 kinase (PI3K) pathway are mediated by IL- 10/DUSP regulation. J Leukoc Biol. J Leukoc Biol. 2010 Dec;88(6):1259-69. Epub 2010 Sep 30.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20884649
2010 Hudson QJ, Kulinski TM, Huetter SP, Barlow DP. Genomic Imprinting Mechanisms In Embryonic And Extra-Embryonic Mouse Tissues. Heredity. 2010 Jul;105(1):45-56. Epub 2010 Mar 17.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20234385
2010 Jager R, Gisslinger H, Passamonti F, Rumi E, Berg T, Gisslinger B, Pietra D, Harutyunyan A, Klampfl T, Olcaydu D, Cazzola M, Kralovics R. Deletions of the transcription factor Ikaros in myeloproliferative neoplasms. Leukemia. 2010 Jul;24(7):1290-8. Epub 2010 May 27.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20508609
2010 Jager R, Kralovics R. Molecular basis and clonal evolution of myeloproliferative neoplasms. Haematologica. 2010 Apr;95(4):526-9.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20378573
2010 Jager R, Kralovics R. Molecular pathogenesis of Philadelphia chromosome-negative chronic myeloproliferative neoplasms. Curr Cancer Drug Targets. 2010 Nov 10.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21062246
2010 Jellusova J, Duber S, Guckel E, Binder CJ, Weiss S, Voll R, Nitschke L. Siglec-G Regulates B1 Cell Survival and Selection. J Immunol. 2010 Sep 15;185(6):3277-84. Epub 2010 Aug 20.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20729333
2010 Knapp S, Frass M. Editorial: Sepsis. Wien Med Wochenschr. 2010 Mar;160(5-6):105-6.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20364411
2010 Knapp S. Update on the role of Toll-like receptors during bacterial infections and sepsis. Wien Med Wochenschr. 2010 Mar;160(5-6):107-11.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20364412
2010 Koerner MV, Barlow DP. Genomic imprinting – an epigenetic gene regulatory model. Curr Opin Genet Dev. 2010 Apr;20(2):164-70.Epub 2010 Feb 12. Review.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20153958
2010 Li J, Rix U, Fang B, Bai Y, Edwards A, Colinge J, Bennett KL, Gao J, Song L, Eschrich S, Superti-Furga G, Koomen J, Haura EB. A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol. 2010 Apr;6(4):291-9. Epub 2010 Feb 28.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20190765
2010 Muellner MK and Nijman SM. Giving Rho(d) Directions. Nat Chem Biol. 2010 Jun;6(6):397-8.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20479746
2010 Nijman SM. Syntehtic lethality: General principles, utility and detection using genetic screens in human cells. FEBS Lett. 2010 Nov 19.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21094158
2010 O’Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol. 2010 Oct;17(10):1218-25. Epub 2010 Oct 3.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20890289
2010 Pedersen TX, Binder CJ, Fredrikson GN, Nilsson J, Bro S, Nielsen LB. The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice. Nephrol Dial Transplant. 2010 Aug;25(8):2486-91. Epub 2010 Feb 17.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20164045
2010 Radwan M, Stiefvater R, Gruner T, Sharif O, Miller I, Marchetti-Deschmann M, Allmaier G, Gemeiner M, Knapp S, Kovarik P, Muller M, Strobl B. Tyrosine kinase 2 controls interleukin-1 production at the translational level. J Immunol. 2010 Sep 15;185(6):3544-53. Epub 2010 Aug 16.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20713887
2010 Schabbauer G, Matt U, Gunzl P, Warszawska J, Furtner T, Hainzl E, Elbau I, Mesteri I, Doninger B, Binder BR, Knapp S. Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia. J Immunol. 2010 Jul 1;185(1):468-76. Epub 2010 May 26.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20505137
2010 Sherbenou DW, Hantschel O, Kaupe I, Willis S, Bumm T, Turaga LP, Lange T, Dao KH, Press RD, Druker BJ, Superti-Furga G, Deininger MW. BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib. Blood. 2010 Oct 28;116(17):3278-85. Epub 2010 Jun 2.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20519627
2010 Ubaida Mohien C, Hartler J, Breitwieser F, Rix U, Remsing Rix L, Winter GE, Thallinger GG, Bennett KL, Superti-Furga G, Trajanoski Z, Colinge J. MASPECTRAS 2: An Integration and Analysis Platform for Proteomic Data. Proteomics. 2010 Jul;10(14):2719-22.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20455215
2010 Wojcik J, Hantschel O, Grebien F, Kaupe I, Bennett KL, Barkinge J, Jones RB, Koide A, Superti-Furga G, Koide S. A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol. 2010 Apr;17(4):519-27. Epub 2010 Mar 28.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20357770
2010 Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J. 2010 Sep 27.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20876212